In the April 2005 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the editorial by Caligiuri et al (Arterioscler Thromb Vasc Biol. 2005:25:655–657.), a reference was mistakenly omitted from the first line of the fourth paragraph. The complete statement, with the appropriate citation and reference, is listed below. The authors regret this error.
Previous studies have shown that blocking IL–18 signaling by overexpression of the IL–18 binding protein (the endogenous inhibitor of IL–18) prevents fatty streak formation and slows progression to mature plaque.14a
14aMallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin–18/interleukin–18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res.2001;89:e41–e45.